Experimentals
General. Unless otherwise specified, commercial reagents and starting materials were purchased from commercial suppliers and used without further purification. Purified water with a resistivity ≥ 18 MΩ cm -1 was used for preparation of buffer solvents. 5'-Dimethoxytrityl-5-iodo-2'-deoxyUridine,3'-[(2-cyanoethyl)(N,N-diisopropyl)]-phosphoramidite was purchased from Glen Research. Unmodified oligonucleotides were purchased from Metabion.
nile red [1] and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine [2] were synthesized according to literature synthesis procedures.Unless otherwise stated, all reactions were carried out at r.t.. Synthetic steps involving azides were performed in the dark. Oligonucleotides were prepared on an Expedite 8909 Synthesizer from Applied Biosystems (ABI) using standard phosphoramidite chemistry on a 1 µmol scale. Reagents and controlled pore glass (CPG) were purchased from ABI and Glen Research. 5-iodo-modified uridine was introduced into DNA by using standard coupling conditions. . The oligonucleotide was quantified by its absorbance at 260 nm using ε 260nm = 28,000 M -1 cm-1 for nile red-dU.
Synthesis of oligodeoxynucleotides
Optical spectroscopy. The oligonucleotides were lyophilized and quantified by their absorbance in 10 mM sodium phosphate buffer at 260 nm on a Varian Cary 100 spectrometer.
Duplexes were formed by heating to 90 °C (10 min) followed by slow cooling. Absorption spectra and melting temperature (2.5 μM DNA, 20-90 °C, 0.7 °C/min, step width 0.5 °C)
were recorded on a Varian Cary 100 spectrometer equipped with a 6×6 cell changer unit. The subscripts "S" and "R" refer to the sample and the reference dye, respectively. A is the extinction of the sample solution at the excitation wavelength; F is the emission integral over the area of interest. The fluorescence quantum yields were determined by the standard method with Cresyl Violet perchlorate in MeOH as reference (Φ Fl = 0.54). [3] Supplementary 
